Pioneer Surgical announces first human use of nanOss Bioactive 3D

883

Pioneer Surgical announced the first-in-human use of nanOss Bioactive 3D, a three-dimensionally shaped addition to its flagship biologic bone graft product line, nanOss Bioactive. 

The new nanOss Bioactive 3D bone graft utilises proprietary nanocrystalline hydroxyapatite as well as a collagen-based biopolymer to promote bone growth in the posterolateral spine.


“We are extremely excited to start the clinical phase of nanOss Bioactive 3D. Three-dimensional shapes are popular in spine surgery and with this addition, we now have one of the most extensive biologic portfolios on the market,” said Shane Ray, general manager – Biologics for Pioneer.